Histological analysis of livers from anti-IL-23 treated Atg5 CD11cKO mice also demonstrated an improvement of NAFLD scoring and decreased hepatic fat content (Fig. 7i–k). The gene discussed is ATG5; the disease is metabolic dysfunction-associated steatotic liver disease.